Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Takeshi Rikiishi"'
Autor:
Masahiro Irie, Tomohiro Nakano, Saori Katayama, Tasuku Suzuki, Kunihiko Moriya, Yuko Watanabe, Nobu Suzuki, Yuka Saitoh‐Nanjyo, Masaei Onuma, Takeshi Rikiishi, Hidetaka Niizuma, Yoji Sasahara, Shigeo Kure
Publikováno v:
Cancer Reports, Vol 5, Iss 8, Pp n/a-n/a (2022)
Abstract Background Better therapeutic options other than conventional chemotherapy for pediatric patients with refractory Langerhans cell histiocytosis (LCH) remain undetermined. Case We successfully treated two patients with refractory and risk org
Externí odkaz:
https://doaj.org/article/0d906eebc17e4d91a6d14d304297da28
Autor:
Masahiro Irie, Tetsuya Niihori, Tomohiro Nakano, Tasuku Suzuki, Saori Katayama, Kunihiko Moriya, Hidetaka Niizuma, Nobu Suzuki, Yuka Saito-Nanjo, Masaei Onuma, Takeshi Rikiishi, Atsushi Sato, Mayumi Hangai, Mitsuteru Hiwatari, Junji Ikeda, Reo Tanoshima, Norio Shiba, Yuki Yuza, Nobuyuki Yamamoto, Yoshiko Hashii, Motohiro Kato, Junko Takita, Miho Maeda, Yoko Aoki, Masue Imaizumi, Yoji Sasahara
Publikováno v:
International Journal of Hematology. 117:598-606
Mutations in the MECOM encoding EVI1 are observed in infants who have radioulnar synostosis with amegakaryocytic thrombocytopenia. MECOM-associated syndrome was proposed based on clinical heterogeneity. Allogeneic hematopoietic stem cell transplantat
Autor:
Kohsuke Imai, Shigeo Kure, Satoshi Okada, Tomohiro Nakano, Tasuku Suzuki, Saori Katayama, Yoji Sasahara, Hidetaka Niizuma, Nao Uchida, Takeshi Rikiishi, Kunihiko Moriya, Masahiro Irie
Publikováno v:
International Journal of Hematology. 112:258-262
Signal transducer and activator of transcription 1 gain-of-function (STAT1 GOF) mutations are the most common cause of chronic mucocutaneous candidiasis (CMC). We report the effect of oral ruxolitinib, an inhibitor of Janus kinase (JAK) family tyrosi
Autor:
Wataru Irie, Yuko Nagoya, Miwa Ozawa, Atsushi Sato, Takeshi Rikiishi, Yoji Sasahara, Hitoshi Shiwaku
Publikováno v:
SSRN Electronic Journal.
Autor:
Hidetaka Niizuma, Nobu Suzuki, Kunihiko Moriya, Yuka Saitoh-Nanjyo, Masaei Onuma, Shigeo Kure, Yuko Watanabe, Masahiro Irie, Tasuku Suzuki, Takeshi Rikiishi, Tomohiro Nakano, Saori Katayama, Yoji Sasahara
Publikováno v:
Cancer Reports. 5
Background Better therapeutic options other than conventional chemotherapy for pediatric patients with refractory Langerhans cell histiocytosis (LCH) remain undetermined. Case We successfully treated two patients with refractory and risk organ negati
Autor:
Hitoshi Terui, Setsuya Aiba, Akiko Hagiwara-Takita, Kenshi Yamasaki, Yuka Saito-Nanjo, Ryoko Shimada-Omori, Kenichiro Tsuchiyama, Takeshi Rikiishi, Yoji Sasahara
Publikováno v:
The Journal of dermatologyREFERENCES. 48(9)
Genome-wide association studies have identified more than 60 susceptibility loci for psoriasis, highlighting the role of genetics in psoriasis development. Although the HLA region is suggested as the most prominent susceptibility locus, the role of t
Autor:
Setsuya Aiba, Takanori Hidaka, Yoji Sasahara, Yoshiko Kagimoto, Kenshi Yamasaki, Reimu Fukui, Yoshiyuki Kusakari, Takeshi Rikiishi, Hitoshi Terui
Publikováno v:
The Journal of dermatologyREFERENCES. 48(7)
Autor:
Asuka Ohta, Satoshi Okamura, Akira Hayakawa, Hiroki Hori, Miyuki Morita-Tominaka, Kyoko Kobayashi, Daisuke Masumoto, Kosuke Kurihara, Takeshi Rikiishi, Yosuke Okumura, Kanako Yano, Zayar Linn, Honami Matsui
Publikováno v:
International journal of clinical oncology. 27(1)
The practice of cancer diagnosis disclosure to children has been changed with the times. The regulations of clinical trials in the 2000s might change the practice in Japan. However, the perspective of this topic among children and adults has not been
Autor:
Hiroyuki Shichino, Kazuko Kudo, Maho Sato, Souichi Adachi, Takeshi Rikiishi, Hiroko Inada, Hiroaki Goto, Ryoji Kobayashi, Miho Maeda, Tatsuo Kuroda, Jun Okamura, Junichiro Fujimoto, Dongmei Qiu, Yasushi Ishida, Chikako Kiyotani, Atsushi Ogawa, Hiroki Hori, Shinji Yoshinaga, Hiroshi Kawaguchi, Atsushi Manabe
Publikováno v:
International Journal of Clinical Oncology. 23:1178-1188
Multidisciplinary therapy has increased the risk of subsequent late effects, but detailed analyses on secondary cancers in childhood cancer survivors (CCSs) are limited in Asian countries. This was a retrospective cohort study comprising 10,069 CCSs
Autor:
Megumi Oda, Hideaki Ohta, Machiko Sawada, Kikuko Kuriyama, Junichi Hara, Takeshi Rikiishi, Souichi Adachi, Hiroki Hori, Kyoko Kobayashi, Kiyoko Kamibeppu, Hirohide Kawasaki, Etsuko Nakagami-Yamaguchi, Sadao Tokimasa, Yoshiko Hashii, Urara Kohdera, Akira Hayakawa
Publikováno v:
Pediatrics International. 59:145-153
Background Quality of life (QOL) as a treatment outcome has not yet been evaluated among patients receiving a specific treatment regimen by treatment phase in a consistent manner. This exploratory cross-sectional study evaluated the QOL of children w